Mayflower Financial Advisors, LLC
Position in ELTX — Elicio Therapeutics, Inc.
CIK 1852930
BOSTON, MA
Position in ELTX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$39,100
-$67,800 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 48 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $1,390,659 across 8 Biotechnology names. ELTX ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,681 | $835,003 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
|
10,000 | $242,000 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
20,212 | $176,956 | |
| 4 | HELP |
Cybin Inc.
|
10,290 | $68,016 | |
| 5 | ELTX |
Elicio Therapeutics, Inc.
This page
|
10,000 | $39,100 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
12,559 | $13,814 | |
| 7 | GNPX |
Genprex, Inc.
|
909 | $10,380 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
11,000 | $5,390 |
All Filings in ELTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,100 | 10,000 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $106,900 | 10,000 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $79,600 | 10,000 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $109,400 | 10,000 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $77,200 | 10,000 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||